COVID-19 – A vascular disease

https://doi.org/10.1016/j.tcm.2020.10.005Get rights and content

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects.

Keywords

Endothelium
Coagulation
Thrombosis
Inflammation
Microvessels

Cited by (0)

View Abstract